Trends in Cardiovascular Medicine
Volume 17, Issue 4 , Pages 134-140 , May 2007

Embryonic Stem Cells for Cardiac Muscle Engineering

  • Wolfram-Hubertus Zimmermann

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Wolfram-Hubertus Zimmermann, MD or Thomas Eschenhagen, MD, Institute of Experimental and Clinical Pharmacology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany. Tel.: +(49) 40-42803-2180; fax: +(49) 40-42803-4876
    • ,
  • Thomas Eschenhagen

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Wolfram-Hubertus Zimmermann, MD or Thomas Eschenhagen, MD, Institute of Experimental and Clinical Pharmacology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany. Tel.: +(49) 40-42803-2180; fax: +(49) 40-42803-4876

References 

  1. Assmus B, Honold J, Schachinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006;355:1222–1232
  2. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763–776
  3. Brambrink T, Hochedlinger K, Bell G, Jaenisch R. ES cells derived from cloned and fertilized blastocysts are transcriptionally and functionally indistinguishable. Proc Natl Acad Sci U S A. 2006;103:933–938
  4. Bursac N, Papadaki M, Cohen RJ, et al. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol. 1999;277:H433–H444
  5. Cai CL, Liang X, Shi Y, et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell. 2003;5:877–889
  6. Carrier RL, Papadaki M, Rupnick M, et al. Cardiac tissue engineering, cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng. 1999;64:580–589
  7. Caspi O, Lesman A, Basevitch Y, et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res. 2007;100:263–272
  8. Cheng L, Sung MT, Cossu-Rocca P, et al. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol. 2007;211:1–9
  9. Chung Y, Klimanskaya I, Becker S, et al. Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature. 2006;439:216–219
  10. Cowan CA, Klimanskaya I, McMahon J, et al. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med. 2004;350:1353–1356
  11. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart, the scientific foundations of cardiac repair. J Clin Invest. 2005;115:572–583
  12. El-Armouche A, Rau T, Zolk O, et al. Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes. FASEB J. 2003;17:437–439
  13. Eppenberger ME, Hauser I, Baechi T, et al. Immunocytochemical analysis of the regeneration of myofibrils in long-term cultures of adult cardiomyocytes of the rat. Dev Biol. 1988;130:1–15
  14. Eschenhagen T, Fink C, Remmers U, et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J. 1997;11:683–694
  15. Eschenhagen T, Zimmermann WH. Engineering myocardial tissue. Circ Res. 2005;97:1220–1231
  16. Furuta A, Miyoshi S, Itabashi Y, et al. Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart, in vivo. Circ Res. 2006;98:705–712
  17. Gepstein L. Derivation and potential applications of human embryonic stem cells. Circ Res. 2002;91:866–876
  18. Guan K, Nayernia K, Maier LS, et al. Pluripotency of spermatogonial stem cellsfrom adult mouse testis. Nature. 2006;440:1199–1203
  19. Guo XM, Zhao YS, Chang HX, et al. Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation. 2006;113:2229–2237
  20. Hipp J, Atala A. Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy. J Exp Clin Assist Reprod. 2004;1:3
  21. Humpherys D, Eggan K, Akutsu H, et al. Epigenetic instability in ES cells and cloned mice. Science. 2001;293:95–97
  22. Kanatsu-Shinohara M, Inoue K, Lee J, et al. Generation of pluripotent stem cells from neonatal mouse testis. Cell. 2004;119:1001–1012
  23. Kattman SJ, Huber TL, Keller GM. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell. 2006;11:723–732
  24. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest. 2001;108:407–414
  25. Klimanskaya I, Chung Y, Becker S. Human embryonic stem cell lines derived from single blastomeres. Nature. 2006;444:481–485
  26. Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest. 1996;98:216–224
  27. Kofidis T, Lenz A, Boublik J, et al. Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. Biomaterials. 2003;24:5009–5014
  28. Laugwitz KL, Moretti A, Lam J, et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature. 2005;433:647–653
  29. Leor J, Aboulafia-Etzion S, Dar A, et al. Bioengineered cardiac grafts, a new approach to repair the infarcted myocardium?. Circulation. 2000;102:III56–III61
  30. Levenberg S, Rouwkema J, Macdonald M, et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol. 2005;23:879–884
  31. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006;355:1199–1209
  32. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest. 1999;103:697–705
  33. Menard C, Hagege AA, Agbulut O, et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet. 2005;366:1005–1012
  34. Moretti A, Caron L, Nakano A, et al. Multipotent embryonic isl1+progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell. 2006;127:1151–1165
  35. Muhlhauser U, Zolk O, Rau T, et al. Atorvastatin desensitizes beta-adrenergic signaling in cardiac myocytes via reduced isoprenylation of G-protein gamma-subunits. FASEB J. 2006;20:785–787
  36. Mummery C, Ward-van Oostwaard D, Doevendans P, et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation. 2003;107:2733–2740
  37. Murry CE, Field LJ, Menasche P, et al. Cell-based cardiac repair: reflections at the 10-year point. Circulation. 2005;112:3174–3183
  38. Nag AC, Zak R. Dissociation of adult mammalian heart into single cell suspension: an ultrastructural study. JAnat. 1979;129:541–559
  39. Naito H, Melnychenko I, Didie M, et al. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation. 2006;114:I72–I78
  40. Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A. 2003;100:12313–12318
  41. Rogge C, Didié M, Naito H, et al. Generation of engineered heart tissue from embryonic stem cell derived cardiomyocytes. Circulation. 2005;112:II-14;(abstract)
  42. Schachinger V, Erbs S, Elsasser A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210–1221
  43. Shannon TR, Wang F, Puglisi J. A mathematical treatment of integrated Ca dynamics within the ventricular myocyte. Biophys J. 2004;87:3351–3371
  44. Shimizu T, Sekine H, Yang J, et al. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J. 2006;20:708–710
  45. Starksen NF, Simpson PC, Bishopric N, et al. Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression. Proc Natl Acad Sci U S A. 1986;83:8348–8350
  46. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676
  47. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–1147
  48. Vrana KE, Hipp JD, Goss AM, et al. Nonhuman primate parthenogenetic stem cells. Proc Natl Acad Sci U S A. 2003;100(Suppl 1):11911–11916
  49. Wakayama T, Tabar V, Rodriguez I, Perry AC. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science. 2001;292:740–743
  50. Wobus AM, Boheler KR. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev. 2005;85:635–678
  51. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364:141–148
  52. Wu SM, Fujiwara Y, Cibulsky SM, et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell. 2006;127:1137–1150
  53. Xu C, Police S. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res. 2002;91:501–508
  54. Zeineddine D, Papadimou E, Mery A. Cardiac commitment of embryonic stem cells for myocardial repair. Methods Mol Med. 2005;112:175–182
  55. Zimmermann WH, Didie M, Wasmeier GH, et al. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation. 2002;106:I151–I157
  56. Zimmermann WH, Schneiderbanger K, Schubert P, et al. Tissue engineering of a differentiated cardiac muscle construct. Circ Res. 2002;90:223–230
  57. Zimmermann WH, Fink C, Kralisch D, Remmers U. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng. 2000;68:106–114
  58. Zimmermann WH, Kehat I, Boy O, et al. Three-dimensional culture induces advanced differentiation of primary rat and human embryonic stem cell derived cardiomyocytes: implications for cardiac tissue engineering. Circulation. 2003;108:IV-243;(abstract)
  59. Zimmermann WH, Melnychenko I, Wasmeier G, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med. 2006;12:452–458
  60. Zwaka TP, Thomson JA. Homologous recombination in human embryonic stem cells. Nat Biotechnol. 2003;21:319–321

PII: S1050-1738(07)00051-5

doi: 10.1016/j.tcm.2007.02.007

Trends in Cardiovascular Medicine
Volume 17, Issue 4 , Pages 134-140 , May 2007

Article Tools

* Image Usage & Resolution